Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

This publication has 18 references indexed in Scilit:

• Establishment of Micrometastatic Carcinoma Cell Lines: a Novel Source of Tumor Cell Vaccines
  JNCI Journal of the National Cancer Institute, 1995
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
  The Lancet, 1994
• Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone Marrow
  Journal of Hematotherapy, 1994
• Clinical Implications of the p53 Tumor-Suppressor Gene
  New England Journal of Medicine, 1993
• Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1993
• Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
  The Lancet, 1992
• The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
  International Journal of Cancer, 1986
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• Site of Recurrence in Patients with Stages I and II Carcinoma of the Lung Resected for Cure
  The Annals of Thoracic Surgery, 1981
• The total cellularity of the bone marrow in man
  Journal of Clinical Pathology, 1962